Company Interview / Broker Moves | CBA, Bendigo Bank, Monadelphous, Nexgen, Pro Medicus

It says CBA's valuation premium may erode as ANZ, WBC show positive earnings revision. It maintains its sell rating and $130 price target.

Morningstar - meantime - maintains fair value estimate for CBA & retains its earnings forecasts..

Sticking with the banks and Citi says Bendigo and Adelaide Bank's quarterly results are tough to digest...it has a sell rating on the stock with $11.00 PT.

Meantime Citi analysts have lifted the target price for Monadelphous after it provided an upbeat half-year and annual forecast. Price target is $28.75.

NexGen Energy has ben Downgraded to Speculative Hold from Speculative Buy Bell Potter...target price $13.05

While Pro Medicus has been Upgraded to Buy from Hold Bell Potter...with a target price of $320.00

And Jefferies has lifted Megaport's rating to a 'buy' with a PT of $20 after its Latitude.sh buy in India.